Search

Mohammed A. Hasan

Examiner (ID: 8846, Phone: (571)272-2331 , Office: P/2872 )

Most Active Art Unit
2872
Art Unit(s)
2872, 2873
Total Applications
2762
Issued Applications
2490
Pending Applications
110
Abandoned Applications
202

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20517620 [patent_doc_number] => 20260041723 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-02-12 [patent_title] => BACTERIOPHAGE COMPOSITIONS FOR TREATING STAPHYLOCOCCUS INFECTION [patent_app_type] => utility [patent_app_number] => 19/309246 [patent_app_country] => US [patent_app_date] => 2025-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15624 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19309246 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/309246
BACTERIOPHAGE COMPOSITIONS FOR TREATING STAPHYLOCOCCUS INFECTION Aug 24, 2025 Pending
Array ( [id] => 19657003 [patent_doc_number] => 20240424068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-26 [patent_title] => USE OF LOW pH ACTIVE ALPHA-1,4;/1,6-GLYCOSIDE HYDROLASES (GLCH) AS A FEED ADDITIVE FOR RUMINANTS TO ENHANCE STARCH DIGESTION [patent_app_type] => utility [patent_app_number] => 18/755419 [patent_app_country] => US [patent_app_date] => 2024-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30295 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18755419 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/755419
USE OF LOW pH ACTIVE ALPHA-1,4;/1,6-GLYCOSIDE HYDROLASES (GLCH) AS A FEED ADDITIVE FOR RUMINANTS TO ENHANCE STARCH DIGESTION Jun 25, 2024 Pending
Array ( [id] => 19691266 [patent_doc_number] => 20250009811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-09 [patent_title] => COMPOSITIONS AND METHODS FOR SUPPRESSING PATHOGENIC ORGANISMS [patent_app_type] => utility [patent_app_number] => 18/748761 [patent_app_country] => US [patent_app_date] => 2024-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38142 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18748761 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/748761
COMPOSITIONS AND METHODS FOR SUPPRESSING PATHOGENIC ORGANISMS Jun 19, 2024 Pending
Array ( [id] => 19402282 [patent_doc_number] => 20240285793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-29 [patent_title] => TOBACCO MOSAIC VIRUS DELIVERY OF MITOXANTRONE FOR CANCER THERAPY [patent_app_type] => utility [patent_app_number] => 18/657338 [patent_app_country] => US [patent_app_date] => 2024-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13292 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18657338 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/657338
TOBACCO MOSAIC VIRUS DELIVERY OF MITOXANTRONE FOR CANCER THERAPY May 6, 2024 Abandoned
Array ( [id] => 20214499 [patent_doc_number] => 12411145 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-09 [patent_title] => Methods for quantifying frataxin activity [patent_app_type] => utility [patent_app_number] => 18/637707 [patent_app_country] => US [patent_app_date] => 2024-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14630 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18637707 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/637707
Methods for quantifying frataxin activity Apr 16, 2024 Issued
Array ( [id] => 19447334 [patent_doc_number] => 20240307464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-19 [patent_title] => SPORE-BASED PROBIOTIC SUPPLEMENTATION IN DOGS AND CONTROL OF ENDOTOXEMIA [patent_app_type] => utility [patent_app_number] => 18/627241 [patent_app_country] => US [patent_app_date] => 2024-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12710 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18627241 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/627241
Spore-based probiotic supplementation in dogs and control of endotoxemia Apr 3, 2024 Issued
Array ( [id] => 19752801 [patent_doc_number] => 20250041366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-06 [patent_title] => BACTERIOPHAGE COMPOSITIONS AND METHODS FOR TREATMENT OF BACTERIAL INFECTIONS [patent_app_type] => utility [patent_app_number] => 18/602659 [patent_app_country] => US [patent_app_date] => 2024-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17395 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18602659 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/602659
BACTERIOPHAGE COMPOSITIONS AND METHODS FOR TREATMENT OF BACTERIAL INFECTIONS Mar 11, 2024 Pending
Array ( [id] => 19263635 [patent_doc_number] => 20240207332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-27 [patent_title] => EDIBLE PLANT PARTS ENRICHED WITH PROBIOTIC BACTERIA [patent_app_type] => utility [patent_app_number] => 18/594570 [patent_app_country] => US [patent_app_date] => 2024-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12114 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18594570 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/594570
Edible plant parts enriched with probiotic bacteria Mar 3, 2024 Issued
Array ( [id] => 19510571 [patent_doc_number] => 20240342257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-17 [patent_title] => BOTULINUM NEUROTOXIN A SUBTYPE 6 AND PHARMACOLOGICAL METHODS OF USE [patent_app_type] => utility [patent_app_number] => 18/592050 [patent_app_country] => US [patent_app_date] => 2024-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8322 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18592050 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/592050
BOTULINUM NEUROTOXIN A SUBTYPE 6 AND PHARMACOLOGICAL METHODS OF USE Feb 28, 2024 Pending
Array ( [id] => 19140464 [patent_doc_number] => 20240139252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-02 [patent_title] => TREATMENT OF VON WILLEBRAND DISEASE [patent_app_type] => utility [patent_app_number] => 18/406008 [patent_app_country] => US [patent_app_date] => 2024-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15268 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 272 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18406008 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/406008
Treatment of von Willebrand disease Jan 4, 2024 Issued
Array ( [id] => 18970448 [patent_doc_number] => 20240050540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-15 [patent_title] => NEUROTOXIN COMPOSITIONS FOR USE IN TREATING HEADACHE [patent_app_type] => utility [patent_app_number] => 18/492533 [patent_app_country] => US [patent_app_date] => 2023-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35924 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -35 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18492533 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/492533
NEUROTOXIN COMPOSITIONS FOR USE IN TREATING HEADACHE Oct 22, 2023 Abandoned
Array ( [id] => 18970404 [patent_doc_number] => 20240050496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-15 [patent_title] => PROBIOTIC COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/490629 [patent_app_country] => US [patent_app_date] => 2023-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6229 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18490629 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/490629
PROBIOTIC COMPOSITION Oct 18, 2023 Abandoned
Array ( [id] => 19065679 [patent_doc_number] => 20240100105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-28 [patent_title] => BACTERIOPHAGE TREATMENT FOR ACNE AND BIOFILMS [patent_app_type] => utility [patent_app_number] => 18/481324 [patent_app_country] => US [patent_app_date] => 2023-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27567 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18481324 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/481324
BACTERIOPHAGE TREATMENT FOR ACNE AND BIOFILMS Oct 4, 2023 Abandoned
Array ( [id] => 18806121 [patent_doc_number] => 20230380450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-30 [patent_title] => PASTURE TREATMENTS FOR ENHANCED CARBON SEQUESTRATION AND REDUCTION IN LIVESTOCK-PRODUCED GREENHOUSE GAS EMISSIONS [patent_app_type] => utility [patent_app_number] => 18/448915 [patent_app_country] => US [patent_app_date] => 2023-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13139 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18448915 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/448915
PASTURE TREATMENTS FOR ENHANCED CARBON SEQUESTRATION AND REDUCTION IN LIVESTOCK-PRODUCED GREENHOUSE GAS EMISSIONS Aug 11, 2023 Pending
Array ( [id] => 18806954 [patent_doc_number] => 20230381287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-30 [patent_title] => FORMULATIONS COMPRISING GLUCOCEREBROSIDASE AND ISOFAGOMINE [patent_app_type] => utility [patent_app_number] => 18/231982 [patent_app_country] => US [patent_app_date] => 2023-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16830 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18231982 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/231982
FORMULATIONS COMPRISING GLUCOCEREBROSIDASE AND ISOFAGOMINE Aug 8, 2023 Pending
Array ( [id] => 18877503 [patent_doc_number] => 20240000872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-04 [patent_title] => NOVEL BACTERIOPHAGE THAT LYSES ACINETOBACTER GENUS BACTERIA HAVING RESISTANCE TO ANTIBIOTICS [patent_app_type] => utility [patent_app_number] => 18/351961 [patent_app_country] => US [patent_app_date] => 2023-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22640 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18351961 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/351961
NOVEL BACTERIOPHAGE THAT LYSES ACINETOBACTER GENUS BACTERIA HAVING RESISTANCE TO ANTIBIOTICS Jul 12, 2023 Abandoned
Array ( [id] => 19120028 [patent_doc_number] => 11963989 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-23 [patent_title] => Application of medical cell CMU-pb-7 in preparation of blood lipid-lowering drugs [patent_app_type] => utility [patent_app_number] => 18/336973 [patent_app_country] => US [patent_app_date] => 2023-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 5142 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 164 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18336973 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/336973
Application of medical cell CMU-pb-7 in preparation of blood lipid-lowering drugs Jun 16, 2023 Issued
Array ( [id] => 18784780 [patent_doc_number] => 20230372412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-23 [patent_title] => DYSOSMOBACTER, A NOVEL BACTERIAL GENUS OF THE GASTROINSTESTINAL MICROBIOTA AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/317309 [patent_app_country] => US [patent_app_date] => 2023-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38251 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18317309 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/317309
None May 14, 2023 Issued
Array ( [id] => 19417394 [patent_doc_number] => 20240293517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-05 [patent_title] => Chimeric endolysin polypeptide, cluster 3b [patent_app_type] => utility [patent_app_number] => 18/314864 [patent_app_country] => US [patent_app_date] => 2023-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8477 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18314864 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/314864
Chimeric endolysin polypeptide, cluster 3b May 9, 2023 Issued
Array ( [id] => 18550789 [patent_doc_number] => 20230248789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-10 [patent_title] => THERAPEUTIC BACTERIOPHAGE COMPOSITIONS FOR TREATING STAPHYLOCOCCUS INFECTION [patent_app_type] => utility [patent_app_number] => 18/301188 [patent_app_country] => US [patent_app_date] => 2023-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17127 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18301188 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/301188
Therapeutic bacteriophage compositions for treating Apr 13, 2023 Issued
Menu